目前的状态和未来的前景在质瘤入侵研究研究
1Department of Neurosurgery, Washoukai Sadamoto Hospital, Advanced Brain Disease Center, 1-6-1 Takehara, Matsuyama 790-0052, Japan.
Brain sciences
|April 27, 2024
概括
质母细胞瘤 (GBM) 是一种致命的脑癌,存活率很低. 研究旨在为这种攻击性的成年瘤寻找新的治疗方法.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 分子病理学分子病理学
背景情况:
- 质母细胞瘤 (GBM) 是成年人中最具攻击性的原发性脑瘤.
- 目前的治疗方法有效性有限,因此平均存活时间仅为15个月.
- 了解GBM的分子复杂性对于治疗进步至关重要.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...